Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOTRONIK 4French for AMBulatory Peripheral Intervention. A Multicenter, Controlled Trial Comparing 4French Versus 6French Femoral Access for Endovascular Treatment of Lower-extremity Peripheral Artery Disease in an Ambulatory Setting: BIO4AMB

NCT03044002 is registered in ClinicalTrials.gov with Biotronik AG as lead sponsor.

NCT NCT03044002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03044002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOTRONIK 4French for AMBulatory Peripheral Intervention. A Multicenter, Controlled Trial Comparing 4French Versus 6French Femoral Access for Endovascular Treatment of Lower-extremity Peripheral Artery Disease in an Ambulatory Setting: BIO4AMB
Lead sponsor
Biotronik AG
Phase
Observational
Overall status
Completed
Start date
March 17, 2017
Completion date
October 20, 2020
Enrollment
821 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

access site complication, outpatient treatment, peripheral artery disease